224 results on '"Hensley, Patrick J."'
Search Results
2. Development and Validation of a Multivariable Nomogram Predictive of Post-Nephroureterectomy Renal Function
3. TRPS1 expression in primary and metastatic prostatic adenocarcinoma, muscle invasive bladder urothelial carcinoma, and breast carcinoma: Is TRPS1 truly specific and sensitive for a breast primary?
4. Oncological Outcomes for Patients with European Association of Urology Very High-risk Non–muscle-Invasive Bladder Cancer Treated with Bacillus Calmette-Guérin or Early Radical Cystectomy
5. Bladder preservation after neoadjuvant therapy – 2021 IBCN updates part 1
6. Contemporary Staging for Muscle-Invasive Bladder Cancer: Accuracy and Limitations
7. Implications of Guideline-based, Risk-stratified Restaging Transurethral Resection of High-grade Ta Urothelial Carcinoma on Bacillus Calmette-Guérin Therapy Outcomes
8. Germline Mutations in African American Men With Prostate Cancer: Incidence, Implications and Diagnostic Disparities
9. Updated European Association of Urology (EAU) Prognostic Factor Risk Groups Overestimate the Risk of Progression in Patients with Non–muscle-invasive Bladder Cancer Treated with Bacillus Calmette-Guérin
10. Urologic Tumors
11. PD30-03 PREDICTING RESPONSE TO INTRAVESICAL BCG IN HIGH RISK NON-MUSCLE INVASIVE BLADDER CANCER USING AN ARTIFICIAL INTELLIGENCE-POWERED PATHOLOGY ASSAY: DEVELOPMENT AND VALIDATION IN AN INTERNATIONAL 12 CENTER COHORT
12. PD27-12 DEVELOPMENT AND VALIDATION OF GENERALIZABLE INTERPRETABLE AI BIOMARKERS TO PREDICT CLINICAL OUTCOMES IN BCG-TREATED PATIENTS WITH NON-MUSCLE INVASIVE BLADDER CANCER
13. MP08-14 PROGNOSTIC SIGNIFICANT OF PATHOLOGIC RESPONSE TO PREOPERATIVE CHEMOTHERAPY IN MUSCLE-INVASIVE UROTHELIAL CARCINOMA OF THE BLADDER WITH SUBTYPE HISTOLOGY
14. PD20-08 RESPONSE TO NEOADJUVANT CHEMOTHERAPY IS ASSOCIATED WITH IMPROVED SURVIVAL IN UPPER TRACT UROTHELIAL CARCINOMA—AN UPPER TRACT COLLABORATIVE NETWORK (UCAN) STUDY
15. Impact of sex on response to BCG in non-muscle invasive bladder cancer patients: a contemporary review from a tertiary care center
16. Germline Predisposition to Prostate Cancer in Diverse Populations
17. Racial disparities in stage at bladder cancer diagnosis in the US Veterans Affairs healthcare system.
18. International Publication Patterns on Operative Management of Wilms Tumor: A Review by Surgeon Specialty and Surgical Modality
19. Reply to Francesco Montorsi, Giuseppe Rosiello, and Giorgio Gandaglia’s Letter to the Editor re: Roberto Contieri, Patrick J. Hensley, Wei Shen Tan, et al. Oncological Outcomes for Patients with European Association of Urology Very High-risk Non–muscle-Invasive Bladder Cancer Treated with Bacillus Calmette-Guérin or Early Radical Cystectomy. Eur Urol Oncol. 2023;6:590–596
20. Influence of lamina propria invasion extension on T1 high‐grade non‐muscle‐invasive bladder cancer in patients undergoing BCG or radical cystectomy
21. Chapter 42 - Historical control: Design, measures, and classic example
22. Competing mortality risk from second primary malignancy in bladder cancer patients following radical cystectomy: Implications for survivorship
23. Prostate tumor neuroendocrine differentiation via EMT: The road less traveled
24. Long-Term Oncological Outcomes in Patients Diagnosed With Nonmetastatic Plasmacytoid Variant of Bladder Cancer: A 20-Year University of Texas MD Anderson Cancer Center Experience
25. Urinary tract cytology showing variant morphology and divergent differentiation
26. Urologic Tumors
27. Longitudinal GFR trends after neoadjuvant chemotherapy prior to nephroureterectomy for upper tract urothelial carcinoma
28. Optimization of Patient Selection for Neoadjuvant Chemotherapy in Muscle-invasive Urothelial Carcinoma of the Bladder
29. Extracellular redox state shift: A novel approach to target prostate cancer invasion
30. The 2023 European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: A Critical Appraisal
31. Locally advanced solitary fibrous tumour of the prostate
32. Urinary tract cytology showing variant morphology and divergent differentiation.
33. Phase II study of pembrolizumab in combination with radiation with or without olaparib in localized high-risk prostate cancer.
34. Phase II trial of ArtemiCoffee for men with biochemical recurrence of prostate cancer after local therapy.
35. Experiences of patients with bladder cancer: A comparison of urban and rural areas.
36. Association of CD47 Expression with Clinicopathologic Characteristics and Survival Outcomes in Muscle Invasive Bladder Cancer
37. Repeat Transurethral Resection of Muscle-invasive Bladder Cancer Prior to Radical Cystectomy Is Prognostic but Not Therapeutic. Reply.
38. Association of epithelial-mesenchymal transition and nuclear cofilin with advanced urothelial cancer
39. A Phase I Dose Escalation and Expansion Study of Epidiolex (Cannabidiol) in Patients with Biochemically Recurrent Prostate Cancer
40. List of contributors
41. Bladder preservation after neoadjuvant therapy - 2021 IBCN updates part 1
42. Competing mortality risk from second primary malignancy in bladder cancer patients following radical cystectomy: Implications for survivorship
43. Predictive value of phenotypic signatures of bladder cancer response to cisplatin-based neoadjuvant chemotherapy
44. All High-Grade Ta Tumors Should Be Classified as High Risk: Bacillus Calmette-Guérin Response in High-Grade Ta Tumors
45. Predictive value of epithelial‐mesenchymal‐transition (EMT) signature and PARP‐1 in prostate cancer radioresistance
46. Predictive Biomarkers in the Management of Bladder Cancer: Perspectives in an Evolving Therapeutic Landscape
47. Reply by Authors
48. Evaluating post radical prostatectomy mechanisms of early continence
49. The 2023 European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: A Critical Appraisal.
50. Management, Surveillance Patterns, and Costs Associated With Low-Grade Papillary Stage Ta Non–Muscle-Invasive Bladder Cancer Among Older Adults, 2004-2013
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.